← Back to Search

Dietary Supplement

Supplement for Ulcerative Colitis

N/A
Waitlist Available
Led By Randal K Buddington, PhD
Research Sponsored by Baptist Memorial Health Care Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
patients with active ulcerative colitis (proof of diagnosis from gastroenterologist), over 18 years old, has over 50% gut remaining, fully connected bowels (no colostomy), currently on 5-aminosalicylates (ASA) drugs, not pregnant or lactating
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months
Awards & highlights

Study Summary

This study tests the hypothesis that a supplement that combines a functional fiber, long chain omega-3 polyunsaturated fatty acids (PUFAs), vitamin D3, vitamin E, and zinc will reduce clinical symptoms, decrease pro-inflammatory cytokines in the blood and ergo decrease inflammation, promote beneficial microbial activity in the colon, and help recovery of the intestinal mucosa of ulcerative colitis (UC) patients compared with a placebo.

Eligible Conditions
  • Ulcerative Colitis

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Reduced inflammatory cytokines
Secondary outcome measures
Decreased intestinal cramping/ pain
Improved microbiome/ increased Short-Chain Fatty acid (SCFA) counts
Reduced bowel movements per day

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: SupplementActive Control1 Intervention
active supplement consisting of a fermentable fiber, omega-3 polyunsaturated fatty acid, vitamin D3, vitamin E, and zinc
Group II: PlaceboPlacebo Group1 Intervention
placebo consisting of rice starch, light olive oil, and vegetable oil

Find a Location

Who is running the clinical trial?

Baptist Memorial Health Care CorporationLead Sponsor
5 Previous Clinical Trials
28,721 Total Patients Enrolled
Randal K Buddington, PhDPrincipal InvestigatorThe University of Memphis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Immunonutrition in Ulcerative Colitis
Katherine Cook 2018. "Immunonutrition in Ulcerative Colitis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03594708.
All > Ulcerative Colitis > Colitis
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top